About Caraway Pharma Private Limited
Data last updated:
Caraway Pharma Private Limited is a private limited company based in Madurai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2016PTC110459. Its GSTIN is 33AAGCC4710J1ZX (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Murugesan Subha and Devarajan Senthilkumar.
Its last annual general meeting (AGM) was held on 30 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 12/2 Sulthan Nagar Cross 4th Street Bibikulam, Madurai, Tamil Nadu, India – 625002.
As per the financials filed for FY 2021, the company reported a revenue of ₹72.97 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net loss of ₹64.82 Lakh (net margin -88.8%) and EBITDA of -₹63.74 Lakh (EBITDA margin -87.4%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website carawaypharmas.com.
Company details
Contact details
Caraway Pharma Private Limited's registered office is in Madurai, Tamil Nadu. Its website is carawaypharmas.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address12/2 Sulthan Nagar Cross 4th Street Bibikulam, Madurai, Tamil Nadu, India – 625002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Caraway Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Caraway Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Caraway Pharma Private Limited, buy the company report.
Financials of Caraway Pharma Private Limited
FY 2021 filings availableCaraway Pharma Private Limited reported revenue of ₹72.97 Lakh (down 54% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 54% in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹63.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹64.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -87.4% | ||||
| Net Profit Margin | -88.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Caraway Pharma Private Limited, buy the company report.
Board of directors of Caraway Pharma Private Limited
Caraway Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murugesan Subha | Director | 18 May 2016 | 10 Years 5 Months | Current |
| Devarajan Senthilkumar | Director | 18 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Caraway Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asteroids Pharmaceutical Private Limited | ₹73.17 Lakh (FY 2025) | 36.0% | Indore, Madhya Pradesh, India | |||
| Abia Pharmaceuticals Private Limited | ₹73.13 Lakh (FY 2024) | -70.0% | Chennai, Tamil Nadu, India | |||
| Pci Bioscience Private Limited | ₹73.08 Lakh (FY 2024) | -14.0% | Mandi Adampur, Haryana, India | |||
| Caraway Pharma Private Limitedthis company | ₹72.97 Lakh (FY 2021) | -₹64.82 Lakh | -88.8% | -54.0% | Madurai, Tamil Nadu, India | |
| Nectar Healthscience Private Limited | ₹72.96 Lakh (FY 2025) | 118.0% | Agra, Uttar Pradesh, India | |||
| Advitam Life Sciences Private Limited | ₹72.9 Lakh (FY 2022) | 27.0% | New Delhi, Delhi, India | |||
| Sloventis Pharma Private Limited | ₹72.66 Lakh (FY 2024) | 11.0% | Nadia, West Bengal, India |
To see the full peer comparison of Caraway Pharma Private Limited, buy the company report.
Auditor
Caraway Pharma Private Limited is audited by ASHOK & DURAI for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK & DURAI | FY 2019 | 000247S |
Shareholding
The shareholding of Caraway Pharma Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Caraway Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jul 2017 | 100114664 | Indian Overseas Bank | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Caraway Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Caraway Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Caraway Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCC4710J1ZX | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Caraway Pharma Private Limited, buy the company report.
Recent activity
Caraway Pharma Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Subramaniam Rajeswari ceased to be Director on 14 Jun 2022.
Frequently asked questions
Caraway Pharma is an active private limited company based in Madurai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2016 (10+ years old) and is registered under CIN U24230TN2016PTC110459.
Caraway Pharma has 2 current directors:
- Murugesan Subha - Director
- Devarajan Senthilkumar - Director
The latest financial statements of Caraway Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 September 2021. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Caraway Pharma is 33AAGCC4710J1ZX, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Caraway Pharma is U24230TN2016PTC110459. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caraway Pharma was incorporated on 18 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Caraway Pharma by revenue are Asteroids Pharmaceutical Private Limited, Abia Pharmaceuticals Private Limited, Pci Bioscience Private Limited, Nectar Healthscience Private Limited, Advitam Life Sciences Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Subramaniam Rajeswari ceased to be Director on 14 Jun 2022. Thrimali Parthasarathy ceased to be Director on 31 Dec 2021. Chiranjeevi ceased to be Director on 27 Jun 2017. Caraway Pharma has 5 board changes on record in total.
Caraway Pharma can be reached through the website carawaypharmas.com. Its registered office is in Madurai, Tamil Nadu, India.
The registered office of Caraway Pharma is at 122 Sulthan Nagar Cross 4th Street Bibikulam, Madurai, Tamil Nadu, India – 625002.
Caraway Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.